Might not "moon" today...
But the trial is now highly de-risked in my opinion. As stated by TT.....the previous massive trial failure was primarily due to poor sound quality across a high number of recordings. They could not get the numbers high enough to provide a viable and reportable outcome. At the very least they will have the numbers to provide complete clarity going into an FDA approval process.
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-15
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
